MoonLake Immunotherapeutics (MLTX)
10.43
-0.34
(-3.16%)
USD |
NASDAQ |
Oct 08, 11:23
MoonLake Immunotherapeutics Total Liabilities (Quarterly) : 145.75M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 145.75M |
| March 31, 2026 | 146.35M |
| December 31, 2025 | 119.95M |
| September 30, 2025 | 123.14M |
| June 30, 2025 | 102.15M |
| March 31, 2025 | 98.68M |
| December 31, 2024 | 24.54M |
| September 30, 2024 | 22.71M |
| June 30, 2024 | 14.85M |
| March 31, 2024 | 11.73M |
| December 31, 2023 | 13.05M |
| September 30, 2023 | 10.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 7.511M |
| March 31, 2023 | 7.685M |
| December 31, 2022 | 8.077M |
| September 30, 2022 | 6.024M |
| June 30, 2022 | 3.876M |
| March 31, 2022 | 206.82M |
| December 31, 2021 | 21.33M |
| September 30, 2021 | 6.084M |
| June 30, 2021 | 4.115M |
| March 31, 2021 | 4.085M |
| December 31, 2020 | 4.150M |
| September 30, 2020 | 0.1435M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 3.973B |
| AC Immune SA | 142.85M |
| CRISPR Therapeutics AG | 904.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 573.95M |
| Shareholders Equity (Quarterly) | 428.20M |
| Debt to Equity Ratio | 0.2371 |
| Current Ratio | 12.56 |
| Net Debt Paydown Yield | -0.32% |